Imaging in StrokeNet: Realizing the Potential of Big Data

David S Liebeskind, Gregory W Albers, Karen Crawford, Colin P Derdeyn, Mark S George, Yuko Y Palesch, Arthur W Toga, Steven Warach, Wenle Zhao, Thomas G Brott, Ralph L Sacco, Pooja Khatri, Jeffrey L Saver, Steven C Cramer, Steven L Wolf, Joseph P Broderick, Max Wintermark, David S Liebeskind, Gregory W Albers, Karen Crawford, Colin P Derdeyn, Mark S George, Yuko Y Palesch, Arthur W Toga, Steven Warach, Wenle Zhao, Thomas G Brott, Ralph L Sacco, Pooja Khatri, Jeffrey L Saver, Steven C Cramer, Steven L Wolf, Joseph P Broderick, Max Wintermark

No abstract available

Keywords: collateral circulation; diagnostic imaging; stroke.

Conflict of interest statement

Conflict(s) of Interest/Disclosure(s)

Liebeskind: Consultant to Stryker (modest), Covidien (modest); employed by the University of California (UC), which holds a patent on retriever devices for stroke.

Albers: Consultant to iSchemaView, Covidien, Lundbeck; equity interest in iSchemaView.

Derdeyn: Consultant to Microvention, Inc (modest), Silk Road and Penumbra (modest); ownership interest in Pulse Therapeutics (modest).

Palesch: DSMB member for Biogen Inc (modest) and Brainsgate Ltd (modest).

Sacco: Consultant to Boehringer- Ingelheim.

Khatri: Research support from Genentech (significant), Penumbra (significant); DSMB member for Biogen Inc (modest).

Saver: Consultant to Covidien, Stryker, BrainsGate, Pfizer, St. Jude Medical; unpaid site investigator for Lundbeck trials and unpaid consultant to Genentech for PRISMS; employed by the University of California (UC), which holds a patent on retriever devices for stroke.

Cramer: Ownership interest (personalRN); consultant for Roche (modest), RAND Corp (modest), Dart Neuroscience (significant).

Broderick: Research support from Genentech (modest); consultant for Pfizer (modest).